Hong Zhang

11PUBLICATIONS
27CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 23, 2026
Efficacy and safety of sibeprenlimab in IgA nephropathy: interim analysis of the China cohort in the phase 3 VISIONARY trial.

|Apr 08, 2026
Endothelin Receptor Antagonist Ambrisentan, Sodium-Glucose Cotransporter 2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy: A Randomized Crossover Trial.

Qinlan Chen, Pei Chen, Lijun Liu

|Jan 21, 2026
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy.

Yongji Zhang, Honghong Zou, Xinran Ni

|Jan 21, 2026
Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Lin-Lin Xu, Xu-Jie Zhou, Wenjian Bi

|Jul 03, 2024
Current understanding and new insights in the treatment of IgA nephropathy.

Yuemiao Zhang, Hong Zhang

|Oct 29, 2021
The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study.

Chen Tang, Feng-Lei Si, Yu-Xuan Yao

Pageof 2

Frequent Collaborators

3 joint publications

Xujie Zhou

3 joint publications

Lijun Liu

2 joint publications

Yuemiao Zhang

2 joint publications

Xu-Jie Zhou